莲花健康(600186) - 2019 Q1 - 季度财报

Financial Performance - Operating revenue for the first quarter was CNY 377,065,181.42, representing a decline of 12.11% year-on-year[12] - Net profit attributable to shareholders was a loss of CNY 41,435,229.87, compared to a loss of CNY 30,307,882.38 in the same period last year[12] - The company reported a net loss of -¥1,784,633,741.87, worsening from -¥1,742,856,329.95 in the previous year[30] - The company reported a net loss of CNY 1,220,852,630.77 for Q1 2019, compared to a net loss of CNY 1,204,638,689.61 in Q1 2018[39] - The company's total revenue for Q1 2019 was approximately ¥320.78 million, a decrease of 17.4% compared to ¥388.32 million in Q1 2018[45] - Operating profit for Q1 2019 was reported at approximately -¥16.19 million, compared to -¥9.38 million in Q1 2018, indicating a worsening performance[45] - The net profit for Q1 2019 was approximately -¥16.21 million, compared to -¥9.77 million in Q1 2018, reflecting a significant increase in losses[45] - The total comprehensive income for Q1 2019 was approximately -¥16.21 million, compared to -¥9.77 million in Q1 2018[48] Cash Flow - Net cash flow from operating activities was a negative CNY 69,022,384.60, worsening from a negative CNY 29,761,956.47 in the previous year[12] - Cash inflow from investment activities was CNY 322,000.00, while cash outflow was CNY 1,514,549.15, resulting in a net cash flow from investment activities of CNY -1,192,549.15[52] - Cash inflow from financing activities reached CNY 44,000,000.00, compared to CNY 26,000,000.00 previously, marking an increase of approximately 69.2%[54] - Net cash flow from financing activities was CNY 41,879,343.38, significantly higher than CNY 24,168,651.78 in the previous period[54] - Total cash inflow from operating activities was CNY 331,926,385.41, a decline from CNY 392,588,018.12, representing a decrease of approximately 15.4%[56] - Total cash outflow from operating activities was CNY 349,421,802.82, down from CNY 389,881,988.16, indicating a reduction of about 10.4%[56] - The net cash flow from operating activities was negative at CNY -17,495,417.41, contrasting with a positive flow of CNY 2,706,029.96 in the previous period[56] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,681,425,930.30, a decrease of 1.59% compared to the end of the previous year[12] - Total assets decreased to ¥1,681,425,930.30 from ¥1,708,542,518.01[28] - Total liabilities increased to ¥2,226,206,497.29 from ¥2,203,462,424.59[30] - The company's total equity decreased to -¥544,780,566.99 from -¥494,919,906.58, indicating a decline in shareholder equity[30] - Cash and cash equivalents decreased by 71.87% to ¥11,093,160.20 from ¥39,428,750.57 due to increased procurement payments[21] - Accounts receivable decreased by 82.75% to ¥4,739,812.00 from ¥27,484,201.76, attributed to increased procurement payments[21] - Long-term borrowings increased by 92.31% to ¥50,000,000.00 from ¥26,000,000.00, reflecting the addition of a new long-term loan during the quarter[21] - Financial expenses rose by 19.95% to ¥10,135,843.84 from ¥8,449,959.50, driven by increased loans and interest expenses[21] Shareholder Information - The total number of shareholders at the end of the reporting period was 87,891[18] - The largest shareholder, Zhejiang Ruikang Investment Co., Ltd., held 11.78% of the shares, amounting to 125,122,472 shares[18] Government Subsidies - The company reported government subsidies recognized in the current period amounting to CNY 160,807.69[14] - Other income increased significantly by 17,307.69% to ¥160,807.69, attributed to government subsidies received during the period[21] Future Outlook - The company has not indicated any significant changes in its future outlook or strategies during the reporting period[24]